FlixBus and Vertelo have signed a Memorandum of Understanding (MoU) to jointly deploy 500 electric intercity coach buses throughout India. The partnership, announced on April 28, 2025, in New Delhi, combines FlixBus’s extensive intercity travel network with Vertelo’s electric mobility ecosystem solutions. FlixBus, which currently connects more than 200 cities across India through its digital-first… Continue reading FlixBus and Vertelo Join Forces to Deploy 500 Electric Intercity Buses in India
Tag: M and A
Flixbus Unveils Ambitious Plan to Introduce 500 More Electric Buses Across India
FlixBus, a global intercity bus operator, has announced an ambitious plant to scale up its electric intercity bus service. It has signed an agreement with Vertelo, an electric vehicle ecosystem provider, to deploy 500 electric intercity buses across India. The FlixBus-Vertelo partnership is a notable development in India’s intercity bus market, aiming to integrate electric… Continue reading Flixbus Unveils Ambitious Plan to Introduce 500 More Electric Buses Across India
MHP acquires 91.77% of UVESA
KYIV, Ukraine, April 28, 2025 /PRNewswire/ — MHP, a leading international food and agri company, announces the successful conclusion of the adherence period related to its Share Purchase Agreement (SPA) with shareholders of Grupo UVESA, one of Spain’s leading poultry producers. Since the signing of the SPA on 20 March 2025 with shareholders representing 41%… Continue reading MHP acquires 91.77% of UVESA
Comac Medical annonce des nominations au sein de sa direction et une expansion internationale
Le remaniement de la direction et les initiatives de croissance stratégique marquent la prochaine phase du développement de Comac Medical sous l’égide d’EdgeCap Partners. SOFIA, Bulgarie, 28 avril 2025 /PRNewswire/ — Comac Medical, une organisation de recherche sous contrat (ORC) à service complet de premier plan en Europe centrale et orientale, annonce aujourd’hui la nomination… Continue reading Comac Medical annonce des nominations au sein de sa direction et une expansion internationale
Comac Medical Announces New Leadership Appointments and International Expansion
Leadership transition and strategic growth initiatives mark the next phase of Comac Medical’s development under EdgeCap Partners. SOFIA, Bulgaria, April 28, 2025 /PRNewswire/ — Comac Medical, a leading full-service Contract Research Organization (CRO) in Central and Eastern Europe, announced today the appointment of a new CEO and Board Chair and the launch of an international… Continue reading Comac Medical Announces New Leadership Appointments and International Expansion
Comac Medical Announces New Leadership Appointments and International Expansion
Leadership transition and strategic growth initiatives mark the next phase of Comac Medical’s development under EdgeCap Partners. SOFIA, Bulgaria, April 28, 2025 /PRNewswire/ — Comac Medical, a leading full-service Contract Research Organization (CRO) in Central and Eastern Europe, announced today the appointment of a new CEO and Board Chair and the launch of an international… Continue reading Comac Medical Announces New Leadership Appointments and International Expansion
TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM’s incentive program
HELLERUP, Denmark, April 28, 2025 /PRNewswire/ — TORM plc (NASDAQ: TRMD) or (NASDAQ: TRMD A) has increased its share capital by 18,769 A-shares (corresponding to a nominal value of USD 187.69) as a result of the exercise of a corresponding number of Restricted Share Units. All new shares are subscribed for in cash at DKK… Continue reading TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM’s incentive program
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
SHANGHAI, April 28, 2025 /PRNewswire/ — YolTech Therapeutics Co.,Ltd, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, announced promising interim clinical data from an investigator-initiated trial (IIT) of YOLT-101 (NCT06458010), and the data has been published on medRxiv. YOLT-101 is an investigational in vivo base editing therapy for the treatment… Continue reading YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
Sonata Software Secures a $73 Million AI-led Digital Modernization Deal with a Leading US TMT Company
This strategic five-year engagement will drive innovation, global scale, and operational excellence through AI-powered Modernization Engineering. EAST BRUNSWICK, N.J. and BENGALURU, India, April 28, 2025 /PRNewswire/ — Sonata Software (NSE: SONATSOFTW) (BSE: 532221), a global leader in Modernization Engineering, today announced a landmark $73 million, five-year transformational engagement with a major US-based company in the… Continue reading Sonata Software Secures a $73 Million AI-led Digital Modernization Deal with a Leading US TMT Company
100 Days Into New Administration, Survey Reveals Key Opportunities for Elected Officials to Restore Voter Confidence in the Economy
Research from Jobs for the Future finds growing economic pessimism and sharp divides across age, gender, and political affiliation — but also strong bipartisan support for skills-forward education and workforce policies BOSTON , April 28, 2025 /PRNewswire/ — At the 100-day milestone of the new presidential administration, American voters are growing increasingly pessimistic about the state… Continue reading 100 Days Into New Administration, Survey Reveals Key Opportunities for Elected Officials to Restore Voter Confidence in the Economy